Some of these predicted MGPs were supported by previously reported experimental evidences, including deregulation of histidine metabolism in Kidney-RCC with PBRM1 mutation [47], and decreased availability of cholesterol upon PIK3CA mutation in human breast epithelial line (MCF10A) [48]. The gene discussed is PBRM1; the disease is renal cell carcinoma.